Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression

Published:2024-08 Issue: Volume: Page:1-4
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Charalampous Charalampos¹,Doucette Kimberley¹²,Chappell Aimee¹²,Vesole David H.¹²³

Affiliation:

1. Division of Medicine, Georgetown University School of Medicine, Washington, DC, USA

2. Division of Hematology and Oncology, Georgetown University School of Medicine, Washington, DC, USA

3. Myeloma Division, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2381647

Reference15 articles.

1. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

2. Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma

3. The Current State of Knowledge About Evolution of Multiple Myeloma to Plasma Cell Leukemia

4. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy

5. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP